Companies / Entegrion
Entegrion
United States
Entegrion is a life sciences company dedicated to providing innovative solutions to improve clinicians’ ability to effectively manage hemostasis in patients.
Entegrion, based in United States, has 1 investor on file, among them Hatteras Venture Partners. Its site was last checked 20 Nov 2026: site answers.
SEC Form D filings
6 filingsFiled by ENTEGRION INC with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Hatteras Venture Partners
62 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (97%), AI & Machine Learning (7%), Enterprise Software (3%).
See Hatteras Venture Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Entegrion and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Hatteras Venture Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/entegrion.com/investors
# also
GET /v1/companies/entegrion.com
GET /v1/companies/entegrion.com/news